On the prognosis of IDDM patients with large kidneys - PubMed (original) (raw)
On the prognosis of IDDM patients with large kidneys
H J Baumgartl et al. Nephrol Dial Transplant. 1998 Mar.
Abstract
Background: Approximately 10-30% of IDDM patients develop diabetic nephropathy depending on the metabolic control. Previous examinations on the significance of the kidney size prior to the manifestation of nephropathy produced varying results.
Methods: The present study, therefore, was designed to assess the correlation between sonographically determined kidney size and kidney function over 8 years in a follow-up examination, and to evaluate a potential risk pattern. Data could be collected from 73 (66%) of 110 IDDM patients with initially normal serum creatinine whose sonographically determined kidney volume (cm3 = L cm x W cm x D cm x pi/6) and kidney function (creatinine, albuminuria, beta2-microglobulin in serum) had been examined in 1986, and who had a diabetes duration of 1 month to 25 years at that time.
Results: 30% (11 of 37) patients with large kidneys (>170 cm3) reached at least one serious renal end-point (increase of serum creatinine by more than 50%, requirement of dialysis or kidney transplantation, or death in end-stage renal disease) versus one of 36 patients with normal kidney size (P<0.002). As many as 42% of patients with large kidneys developed abnormal creatinine values (>106 micromol/l) in contrast to only 20% of the patients with normal kidney volume (P<0.05). Six of seven patients with a more than 50% increase of serum creatinine from baseline showed large kidneys in 1986, but had a normal serum creatinine, and four also a normal urine albumin excretion. Furthermore all five patients with more severe end-points (two deaths in end-stage renal disease and three patients presently requiring dialysis) exhibited either an increased serum creatinine or large kidneys at baseline; four of these, however, were still in the normoalbuminuric state in 1986.
Conclusions: These results indicate that large kidneys might be a morphological marker for subsequent diabetic nephropathy, and as a consequence, renal insufficiency.
Similar articles
- [Sonographic changes in the size of the kidneys in type I diabetes as a method of early detection of diabetic nephropathy].
Banholzer P, Haslbeck M, Edelmann E, Sager P, Staudigl K, Mehnert H. Banholzer P, et al. Ultraschall Med. 1988 Dec;9(6):255-9. doi: 10.1055/s-2007-1011639. Ultraschall Med. 1988. PMID: 3070748 German. - Large kidneys predict poor renal outcome in subjects with diabetes and chronic kidney disease.
Rigalleau V, Garcia M, Lasseur C, Laurent F, Montaudon M, Raffaitin C, Barthe N, Beauvieux MC, Vendrely B, Chauveau P, Combe C, Gin H. Rigalleau V, et al. BMC Nephrol. 2010 Mar 3;11:3. doi: 10.1186/1471-2369-11-3. BMC Nephrol. 2010. PMID: 20199663 Free PMC article. - Implication of decreased serum complement 3 in patients with diabetic nephropathy.
Zhang J, Wang Y, Zhang R, Li H, Han Q, Guo R, Wang T, Li L, Liu F. Zhang J, et al. Acta Diabetol. 2018 Jan;55(1):31-39. doi: 10.1007/s00592-017-1060-4. Epub 2017 Oct 17. Acta Diabetol. 2018. PMID: 29043511 - [Diabetic nephropathy: significance of microalbuminuria and proteinuria in Type I and Type II diabetes mellitus].
Lehmann R, Spinas GA. Lehmann R, et al. Praxis (Bern 1994). 1995 Oct 31;84(44):1265-71. Praxis (Bern 1994). 1995. PMID: 7491450 Review. German. - Treatment of diabetic nephropathy with angiotensin II receptor antagonist.
Lewis EJ, Lewis JB. Lewis EJ, et al. Clin Exp Nephrol. 2003 Mar;7(1):1-8. doi: 10.1007/s101570300000. Clin Exp Nephrol. 2003. PMID: 14586737 Review.
Cited by
- Knockout of Na-glucose transporter SGLT2 attenuates hyperglycemia and glomerular hyperfiltration but not kidney growth or injury in diabetes mellitus.
Vallon V, Rose M, Gerasimova M, Satriano J, Platt KA, Koepsell H, Cunard R, Sharma K, Thomson SC, Rieg T. Vallon V, et al. Am J Physiol Renal Physiol. 2013 Jan 15;304(2):F156-67. doi: 10.1152/ajprenal.00409.2012. Epub 2012 Nov 14. Am J Physiol Renal Physiol. 2013. PMID: 23152292 Free PMC article. - Renal function in diabetic disease models: the tubular system in the pathophysiology of the diabetic kidney.
Vallon V, Thomson SC. Vallon V, et al. Annu Rev Physiol. 2012;74:351-75. doi: 10.1146/annurev-physiol-020911-153333. Annu Rev Physiol. 2012. PMID: 22335797 Free PMC article. Review. - Erk 1,2 phosphorylates p27(Kip1): Functional evidence for a role in high glucose-induced hypertrophy of mesangial cells.
Wolf G, Reinking R, Zahner G, Stahl RA, Shankland SJ. Wolf G, et al. Diabetologia. 2003 Aug;46(8):1090-9. doi: 10.1007/s00125-003-1163-z. Epub 2003 Jul 10. Diabetologia. 2003. PMID: 12856081 - A Computational Model of Kidney Function in a Patient with Diabetes.
Hu R, Layton A. Hu R, et al. Int J Mol Sci. 2021 May 29;22(11):5819. doi: 10.3390/ijms22115819. Int J Mol Sci. 2021. PMID: 34072329 Free PMC article. Review. - Sex-Specific Computational Models of Kidney Function in Patients With Diabetes.
Swapnasrita S, Carlier A, Layton AT. Swapnasrita S, et al. Front Physiol. 2022 Jan 26;13:741121. doi: 10.3389/fphys.2022.741121. eCollection 2022. Front Physiol. 2022. PMID: 35153824 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous